Skip to content

Biplr Im En Pac Leads (430-07, 432-03, 436-02 & 07, 438-05 & 07)

by Intermedics, Inc.

510(k) K962174

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)ST Traditional NumberK962174 Date21 Aug 1996DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
ST

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Bipolar Implantable Endocardial Pacing Leads are classified as Permanent Pacemaker Electrodes, designed to deliver electrical stimulation to the myocardium for long-term cardiac pacing. These bipolar leads facilitate precise pacing by connecting to implantable pulse generators, ensuring reliable electrical conduction within the heart.

These leads are supplied sterile and intended for single-use implantation. They are regulated under FDA 510(k) clearance (K962174) as a Class 3 device, with a product code of DTB. Each model (430-07, 432-03, 436-02 & 07, 438-05 & 07) is tracked individually, adhering to substantial equivalence requirements for permanent pacemaker electrodes.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these leads reusable or intended for single-use only, and how should they be handled before implantation?

    These leads are explicitly designed for single-use only and are supplied sterile by the manufacturer. They must remain in their sterile packaging until immediately before implantation to ensure proper infection control and functionality.

  • What models are available, and how do they differ in terms of application or design?

    The Bipolar Implantable Endocardial Pacing Leads come in five distinct models: 430-07, 432-03, 436-02 & 07, and 438-05 & 07. While the exact differences in design or application aren’t specified, each model is tracked individually under FDA regulations, indicating potential variations in lead characteristics (e.g., length, electrode configuration, or pacing thresholds) tailored for specific clinical needs.

  • How should these leads be stored, and what are the key considerations for maintaining their integrity?

    Since these leads are sterile and single-use, they should be stored in their original, unopened packaging in a clean, dry environment away from direct sunlight or extreme temperatures. The packaging must remain intact until use to preserve sterility and prevent contamination.

  • What regulatory pathway was followed for FDA clearance, and how does this affect their use in clinical settings?

    These leads were cleared via the FDA 510(k) process (K962174) under the Class 3 device classification, with a product code of DTB (Permanent Pacemaker Electrodes). This means they underwent a premarket submission to demonstrate substantial equivalence to a legally marketed predicate device, ensuring compliance with safety and performance standards for long-term cardiac pacing applications.